Samsung Faces Setbacks in AI Chip Market Amid Competition 
Bitcoin ETFs on Brink of Toppling Satoshi Nakamoto’s Legendary $68 Billion BTC Fortress 
Cybertruck Owners Shocked as GEICO Drops Coverage—Tesla Drivers Scramble for Insurance 
Hong Kong Ramps Up Crypto Licenses: 11 Exchanges Await Approval by Year’s End 
Ares Management to Acquire GLP Capital Partners' Global Operations 
Dollar Reaches Seven-Week High Amid Changing US Rate Outlook and Middle East Tensions 
$1500 Child Stimulus Payment 2024: A Lifeline for New Parents? Families Are 'Desperate' for This Financial Boost 
Japan’s Metaplanet Goes All-In on Bitcoin, Grabs $6.92M in BTC and Sees Stock Rocket by 11%! 
Mainland Chinese Stocks Surge Amid Stimulus Optimism 
Japan’s Yen Hits 2-Month Low Amid US Dollar Surge and Middle East Conflict 
Gas isn’t a good alternative to coal – South Africa should focus on solar, wind and green hydrogen 
Cybertruck Faces European Ban: Tesla's Futuristic Truck Could Be Barred Over Safety Fears 
Nvidia Stock Skyrockets, Pushing AI Tokens NEAR, TAO, FET Into Overdrive—What’s Next? 
Citi Predicts NVIDIA Margins to Bottom Out in Q1 2025, Growth to Follow Blackwell Launch 
Standard Chartered Forecasts 5X Solana Surge by 2025 with Trump Win, SOL ETF Could Spark Rally 
Goldman Sachs Lowers U.S. Recession Odds to 15% Following Strong Job Growth 
Lotte Biologics unveiled a landmark $3 billion partnership with Incheon's city government, Lotte Corporation, and Incheon Free Economic Zone (IFEZ) to establish major biotech production plants in Songdo. This monumental move accelerates the biotech giant's ambitious aim of a combined production capacity of 360,000 liters by 2030.
Lotte Biologics said on Tuesday, June 20, that the MOU is its first step into building the facilities in the region. As per Korea Joongang Daily, the other parties in the project are Lotte Corporation and the Incheon Free Economic Zone (IFEZ).
The contract signing ceremony was held at the IFEZ HQ in Songdo, and executives of the companies were present, including Lotte Biologics’ CEO, Richard Lee; IFEZ’s commissioner, Kim Jin Young; Lotte Corp. president, Lee Hun Ki; and Mayor of Incheon Metropolitan City, Yoo Jeong Bok.
The construction of the production facilities is part of the biotech firm’s plan to erect three new factories that will have a combined production facility of 360,000 liters by the year 2030. The plan was first unveiled in January this year.
The industrial complex will also be a place where the start-up, Bio-Venture Initiative, is expected to open a plant and facilitate possible technological cooperation. Lotte Biologics is planning a groundbreaking event for the construction, and this may happen soon.
This agreement highlights the enthusiastic response from Incheon Metropolitan City and Incheon Free Economic Zone regarding LOTTE BIOLOGICS’ intention to establish a major presence in Songdo,” Lotte Biologic’s chief executive officer said in a press release. “With the goal of commencing construction on the Mega Plant within the year, LOTTE BIOLOGICS will actively cooperate with Incheon Metropolitan City and Incheon Free Economic Zone to swiftly facilitate a land purchase agreement, with the enthusiastic support of LOTTE Corporation.”
Photo by: Lotte Biologics Newsroom
